These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1228 related articles for article (PubMed ID: 19669878)
1. Surveillance in Barrett's esophagus: an audit of practice. Ajumobi A; Bahjri K; Jackson C; Griffin R Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878 [TBL] [Abstract][Full Text] [Related]
2. Audit of a Barrett's epithelium surveillance database. Basu KK; Pick B; de Caestecker JS Eur J Gastroenterol Hepatol; 2004 Feb; 16(2):171-5. PubMed ID: 15075990 [TBL] [Abstract][Full Text] [Related]
3. Barrett's esophagus: a retrospective analysis of 13 years surveillance. Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769 [TBL] [Abstract][Full Text] [Related]
4. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies? Kunzmann AT; Coleman HG; Johnston BT; Turkington RC; McManus D; Anderson LA; Thrift AP Dig Dis Sci; 2021 Jun; 66(6):1965-1973. PubMed ID: 32734400 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia. Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431 [TBL] [Abstract][Full Text] [Related]
6. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182 [TBL] [Abstract][Full Text] [Related]
7. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Weston AP; Badr AS; Hassanein RS Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296 [TBL] [Abstract][Full Text] [Related]
8. Dysplasia in Random Biopsies from Barrett's Surveillance Is an Important Marker for More Severe Pathology. Noordzij IC; Van Loon van de Ende MCM; Curvers WL; van Lijnschoten G; Huysentruyt CJ; Schoon EJ Dig Dis Sci; 2021 Jun; 66(6):1957-1964. PubMed ID: 32661766 [TBL] [Abstract][Full Text] [Related]
9. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018 [TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma. Hillman LC; Chiragakis L; Clarke AC; Kaushik SP; Kaye GL J Gastroenterol Hepatol; 2003 May; 18(5):526-33. PubMed ID: 12702044 [TBL] [Abstract][Full Text] [Related]
11. The diagnosis and management of Barrett's esophagus. DeMeester SR; DeMeester TR Adv Surg; 1999; 33():29-68. PubMed ID: 10572561 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide. Ghaus S; Neumann H; Muhammad H; Tontini GE; Ishaq S Dig Dis Sci; 2016 Aug; 61(8):2185-2193. PubMed ID: 27038446 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association. Wani S; Rubenstein JH; Vieth M; Bergman J Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561 [TBL] [Abstract][Full Text] [Related]
14. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia. Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470 [TBL] [Abstract][Full Text] [Related]
15. Barrett's surveillance identifies patients with early esophageal adenocarcinoma. Wong T; Tian J; Nagar AB Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324 [TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia. Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452 [TBL] [Abstract][Full Text] [Related]
17. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. O'Connor JB; Falk GW; Richter JE Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525 [TBL] [Abstract][Full Text] [Related]
18. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus. Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357 [TBL] [Abstract][Full Text] [Related]
19. Screening and surveillance for complications related to gastroesophageal reflux disease. Spechler SJ Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938 [TBL] [Abstract][Full Text] [Related]
20. Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study. Visrodia K; Iyer PG; Schleck CD; Zinsmeister AR; Katzka DA Dig Dis Sci; 2016 Jan; 61(1):158-67. PubMed ID: 25956705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]